{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:07:50Z","timestamp":1789456070512,"version":"build-2803163510"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["APQ-00634-20"],"award-info":[{"award-number":["APQ-00634-20"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is characterized by complex immune responses, with monocytes playing a central role in disease pathogenesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to evaluate the profiles of monocytes and their receptor expression during the first week of hospitalization in unvaccinated patients with COVID-19, stratified by clinical outcome: discharged or deceased.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Peripheral mononuclear cells from hospitalized patients were analyzed by flow cytometry to characterize classical, intermediate, and non-classical monocytes, along with the expression of CD169, CD209, and TLR2, TLR3, TLR4, and TLR9.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>Patients in whom death was the outcome exhibited a significant reduction in classical monocytes and an expansion of non-classical monocytes early during hospitalization. Additionally, non-classical monocytes from deceased patients showed increased expression of CD169 and greater intensity of CD209 expression. Enhanced expression of TLR2 across all monocyte subsets and increased TLR4 expression specifically in non-classical monocytes were also associated with mortality. Correlation network analysis revealed more complex and dysregulated interactions among monocyte subsets and immune markers in deceased patients compared with discharged individuals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings demonstrate that, during the first week of hospitalization, alterations in monocyte distribution and activation status are strongly associated with COVID-19 severity. Increased expression of CD169, CD209, TLR2, and TLR4, particularly in non-classical monocytes, reflects heightened innate immune activation and may contribute to poorer disease outcomes. Collectively, these results highlight the potential of monocyte subsets and their associated receptors as early prognostic biomarkers and provide insight into the immunopathogenesis of severe COVID-19.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1882388","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:23:52Z","timestamp":1789453432000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Early monocyte subset signatures predict outcomes in unvaccinated COVID-19 patients"],"prefix":"10.3389","volume":"17","author":[{"given":"Fabr\u00edcio Marcus Silva","family":"Oliveira","sequence":"first","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz, Fiocruz, Instituto Ren\u00e9 Rachou, Fiocruz Minas, Oswaldo Cruz Foundation, Fiocruz","place":["Belo Horizonte, Minas Gerais, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f4nica Maria Magalh\u00e3es","family":"Caetano","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz, Fiocruz, Instituto Ren\u00e9 Rachou, Fiocruz Minas, Oswaldo Cruz Foundation, Fiocruz","place":["Belo Horizonte, Minas Gerais, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa Lilian","family":"de Oliveira","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz, Fiocruz, Instituto Ren\u00e9 Rachou, Fiocruz Minas, Oswaldo Cruz Foundation, Fiocruz","place":["Belo Horizonte, Minas Gerais, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Vaz de Melo","family":"Mambrini","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz, Fiocruz, Instituto Ren\u00e9 Rachou, Fiocruz Minas, Oswaldo Cruz Foundation, Fiocruz","place":["Belo Horizonte, Minas Gerais, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Santos","family":"Rezende","sequence":"additional","affiliation":[{"name":"Risoleta Tolentino Neves Hospitalonte","place":["Belo Horiz, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina Pinheiro Rocha","family":"Fantini","sequence":"additional","affiliation":[{"name":"ECMO Minas","place":["Belo Horizonte, Minas Gerais, Brazil"]},{"name":"Materdei Hospital","place":["Belo Horizonte, Minas Gerais, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago Ant\u00f4nio De Oliveira","family":"Mendes","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Federal University of Vi\u00e7osa","place":["Vi\u00e7osa, Minas Gerais, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrique Cerqueira","family":"Guimar\u00e3es","sequence":"additional","affiliation":[{"name":"Risoleta Tolentino Neves Hospitalonte","place":["Belo Horiz, Brazil"]},{"name":"ECMO Minas","place":["Belo Horizonte, Minas Gerais, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline Ara\u00fajo","family":"Fiuza","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz, Fiocruz, Instituto Ren\u00e9 Rachou, Fiocruz Minas, Oswaldo Cruz Foundation, Fiocruz","place":["Belo Horizonte, Minas Gerais, Brazil"]},{"name":"Department of Pathology and Parasitology, Federal University of Alfenas","place":["Alfenas, Minas Gerais, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soraya Torres","family":"Gaze","sequence":"additional","affiliation":[{"name":"Funda\u00e7\u00e3o Oswaldo Cruz, Fiocruz, Instituto Ren\u00e9 Rachou, Fiocruz Minas, Oswaldo Cruz Foundation, Fiocruz","place":["Belo Horizonte, Minas Gerais, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.chom.2020.03.002","article-title":"A sequence homology and bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2","volume":"27","author":"Grifoni","year":"2020","journal-title":"Cell Host Microbe"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/science.abf4063","article-title":"Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection","volume":"371","author":"Dan","year":"2021","journal-title":"Science"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-020-01961-4","article-title":"Immuno-epidemiology and pathophysiology of coronavirus disease 2019 (COVID-19)","volume":"98","author":"Olwenyi","year":"2020","journal-title":"J Mol Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31866-3","article-title":"Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1\/2 studies from Russia","volume":"396","author":"Logunov","year":"2020","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31604-4","article-title":"Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1\/2, single-blind, randomised controlled trial","volume":"396","author":"Folegatti","year":"2020","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31605-6","article-title":"Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"396","author":"Zhu","year":"2020","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2022483","article-title":"An mRNA vaccine against SARS-CoV-2 \u2014 preliminary report","volume":"383","author":"Jackson","year":"2020","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04702-4","article-title":"Fc\u03b3R-mediated SARS-CoV-2 infection of monocytes activates inflammation","volume":"606","author":"Junqueira","year":"2022","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.cell.2019.08.009","article-title":"Fate mapping via Ms4a3-expression history traces monocyte-derived cells","volume":"178","author":"Liu","year":"2019","journal-title":"Cell"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01907","article-title":"In vivo differentiation of human monocytes","volume":"10","author":"Coillard","year":"2019","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-02-258558","article-title":"Nomenclature of monocytes and dendritic cells in blood","volume":"116","author":"Ziegler-Heitbrock","year":"2010","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/sji.12883","article-title":"Pattern of human monocyte subpopulations in health and disease","volume":"92","author":"O\u017ca\u0144ska","year":"2020","journal-title":"Scand J Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02035","article-title":"Human monocyte subsets and phenotypes in major chronic inflammatory diseases","volume":"10","author":"Kapellos","year":"2019","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1186\/s44158-023-00090-x","article-title":"Kinetics of CD169, HLA-DR, and CD64 expression as predictive biomarkers of SARS-CoV2 outcome","volume":"3","author":"Gatti","year":"2023","journal-title":"J Anesthesia Analgesia Crit Care"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab599","article-title":"Monocyte CD169 expression as a biomarker in the early diagnosis of coronavirus disease 2019","volume":"223","author":"Bedin","year":"2021","journal-title":"J Infect Dis"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009576","article-title":"DC\/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist","volume":"17","author":"Th\u00e9paut","year":"2021","journal-title":"PloS Pathog"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1039\/d2cc00121g","article-title":"Glycomimetic ligands block the interaction of SARS-CoV-2 spike protein with C-type lectin co-receptors","volume":"58","author":"Pollastri","year":"2022","journal-title":"Chem Commun"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.6.2634","article-title":"DC-SIGN (CD209) expression is IL-4 dependent and is negatively regulated by IFN, TGF-beta, and anti-inflammatory agents","volume":"168","author":"Relloso","year":"2002","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(00)80693-5","article-title":"Identification of DC-SIGN, a novel dendritic cell\u2013specific ICAM-3 receptor that supports primary immune responses","volume":"100","author":"Geijtenbeek","year":"2000","journal-title":"Cell"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2588-y","article-title":"Longitudinal analyses reveal immunological misfiring in severe COVID-19","volume":"584","author":"Lucas","year":"2020","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1021\/acscentsci.0c01537","article-title":"CD209L\/L-SIGN and CD209\/DC-SIGN act as receptors for SARS-CoV-2","volume":"7","author":"Amraei","year":"2021","journal-title":"ACS Cent Sci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.250476497","article-title":"The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors","volume":"97","author":"Ozinsky","year":"2000","journal-title":"PNAS"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Abbafati","year":"2020","journal-title":"Lancet"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.9.4531","article-title":"Quantitative expression of Toll-Like Receptor 1\u201310 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides","volume":"168","author":"Hornung","year":"2002","journal-title":"J Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.103153","article-title":"Prophylactic intranasal administration of a TLR2\/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model","volume":"63","author":"Proud","year":"2021","journal-title":"EBioMedicine"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8874339","article-title":"COVID\u201019 and Toll\u2010Like Receptor 4 (TLR4): SARS\u2010CoV\u20102 may bind and activate TLR4 to increase ACE2 expression, facilitating entry and causing hyperinflammation","volume":"2021","author":"Aboudounya","year":"2021","journal-title":"Mediators Inflammation"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e06187","article-title":"SARS-CoV-2 spike protein S1 subunit induces pro-inflammatory responses via toll-like receptor 4 signaling in murine and human macrophages","volume":"7","author":"Shirato","year":"2021","journal-title":"Heliyon"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-00937-x","article-title":"TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines","volume":"22","author":"Zheng","year":"2021","journal-title":"Nat Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26728","article-title":"mTOR inhibition in COVID\u201019: a commentary and review of efficacy in RNA viruses","volume":"93","author":"Karam","year":"2021","journal-title":"J Med Virol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1186\/s12879-022-07437-9","article-title":"mRNA expression of toll-like receptors 3, 7, 8, and 9 in the nasopharyngeal epithelial cells of coronavirus disease 2019 patients","volume":"22","author":"Bagheri-Hosseinabadi","year":"2022","journal-title":"BMC Infect Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/mbio.00638-15","article-title":"Toll-like receptor 3 signaling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection","volume":"6","author":"Totura","year":"2015","journal-title":"mBio"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2020.07.007","article-title":"Human in vivo-differentiated monocyte-derived dendritic cells","volume":"86","author":"Tang-Huau","year":"2019","journal-title":"Semin Cell Dev Biol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"9607","DOI":"10.3389\/fimmu.2021.654165","article-title":"Immunity to SARS-CoV-2: lessons learned","volume":"12","author":"Fergie","year":"2021","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2021.03.016","article-title":"Durability of immunity to SARS-CoV-2 and other respiratory viruses","volume":"29","author":"Siggins","year":"2021","journal-title":"Trends Microbiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-36397-6","article-title":"Waning cellular immune responses and predictive factors in maintaining cellular immunity against SARS-CoV-2 six months after BNT162b2 mRNA vaccination","volume":"13","author":"Ishii","year":"2023","journal-title":"Sci Rep"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-10-4094","article-title":"IMMUNOBIOLOGY MHC class II \/ CD38 \/ CD9 : a lipid-raft \u2013 dependent signaling complex in human monocytes","volume":"106","author":"Setterblad","year":"2005","journal-title":"Blood"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.2147\/prom.s144425","article-title":"Impact of novel antifibrotic therapy on patient outcomes in idiopathic pulmonary fibrosis: patient selection and perspectives","volume":"9","author":"Graney","year":"2018","journal-title":"Patient Related Outcome Measures"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-03-771261","article-title":"Circulatory and maturation kinetics of human monocyte subsets in vivo","volume":"130","author":"Tak","year":"2017","journal-title":"Blood"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20170355","article-title":"The fate and lifespan of human monocyte subsets in steady state and systemic inflammation","volume":"214","author":"Patel","year":"2017","journal-title":"J Exp Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000542652","article-title":"Human blood non-classical\/classical monocyte cells are heterogeneously presented in severe COVID-19 and correlate with disease activity","volume":"17","author":"Zhou","year":"2025","journal-title":"J Innate Immun"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202013038","article-title":"Monocytopenia, monocyte morphological anomalies and hyperinflammation characterise severe COVID-19 in type 2 diabetes","volume":"12","author":"Alzaid","year":"2020","journal-title":"EMBO Mol Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1172\/JCI140335","article-title":"COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes","volume":"130","author":"S\u00e1nchez-Cerrillo","year":"2020","journal-title":"J Clin Invest"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202149680","article-title":"Alterations of blood monocyte subset distribution and surface phenotype are linked to infection severity in COVID-19 inpatients","volume":"52","author":"Haschka","year":"2022","journal-title":"Eur J Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.289","article-title":"Role of the interferons in CD64 and CD169 expressions in whole blood: relevance in the balance between viral- or bacterial-oriented immune responses","volume":"8","author":"Bourgoin","year":"2020","journal-title":"Immun Inflammation Dis"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/immu.200310029","article-title":"The C\u2010type lectin DC\u2010SIGN (CD209) is an antigen\u2010uptake receptor for Candida albicans on dendritic cells","volume":"33","author":"Cambi","year":"2003","journal-title":"Eur J Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0405695101","article-title":"L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus","volume":"101","author":"Cormier","year":"2004","journal-title":"PNAS"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-023-00973-x","article-title":"Prognostic models in COVID-19 infection that predict severity: a systematic review","volume":"38","author":"Buttia","year":"2023","journal-title":"Eur J Epidemiol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-020-0485-2","article-title":"COVID-19 patients with hypertension have more severe disease: a multicenter retrospective observational study","volume":"43","author":"Huang","year":"2020","journal-title":"Hypertens Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0331-4","article-title":"Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages","volume":"20","author":"Merad","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2020.03.022","article-title":"Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis","volume":"506","author":"Lippi","year":"2020","journal-title":"Clin Chim Acta"},{"key":"B51","doi-asserted-by":"crossref","DOI":"10.24966\/MSR-5657\/100015","article-title":"Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: A retrospective cohort study","volume":"3","author":"Zhou","year":"2020","journal-title":"J Med Study Res"},{"key":"B52","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1080\/10408363.2020.1770685","article-title":"Biomarkers associated with COVID-19 disease progression","volume":"57","author":"Ponti","year":"2020","journal-title":"Crit Rev Clin Lab Sci"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2020-0198","article-title":"Laboratory abnormalities in patients with COVID-2019 infection","volume":"58","author":"Lippi","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1252556","article-title":"Retrospective cohort study to evaluate the continuous use of anticholesterolemics and diuretics in patients with COVID-19","volume":"10","author":"Oliveira","year":"2023","journal-title":"Front Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1882388\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:23:54Z","timestamp":1789453434000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1882388\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":55,"alternative-id":["10.3389\/fimmu.2026.1882388"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1882388","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"article-number":"1882388"}}